''Pacemaker'' f-channels mediating the hyperpolarization-activated nonselective cation current I f are directly regulated by cAMP. Accordingly, the activity of f-channels increases when cellular cAMP levels are elevated (e.g., during sympathetic stimulation) and decreases when they are reduced (e.g., during vagal stimulation). Although these biophysical properties seem to make f-channels ideal molecular targets for heart rate regulation by the autonomic nervous system, the exact contribution of the major I f-mediating cardiac isoforms HCN2 and HCN4 to sinoatrial node (SAN) function remains highly controversial. To directly investigate the role of cAMP-dependent regulation of hyperpolarization activated cyclic nucleotide activated (HCN) channels in SAN activity, we generated mice with heart-specific and inducible expression of a human HCN4 mutation (573X) that abolishes the cAMP-dependent regulation of HCN channels. We found that hHCN4 -573X expression causes elimination of the cAMP sensitivity of I f and decreases the maximum firing rates of SAN pacemaker cells. In conscious mice, hHCN4 -573X expression leads to a marked reduction in heart rate at rest and during exercise. Despite the complete loss of cAMP sensitivity of If, the relative extent of SAN cell frequency and heart rate regulation are preserved. Our data demonstrate that cAMPmediated regulation of If determines basal and maximal heart rates but does not play an indispensable role in heart rate adaptation during physical activity. Our data also reveal the pathophysiologic mechanism of hHCN4 -573X-linked SAN dysfunction in humans.
H
eart automaticity is a fundamental physiological function in higher organisms. The dominant pacemaker of mammalian hearts is the sinoatrial node (SAN). Dysfunction or failure of SAN activity in humans may lead to an abnormally low heart rate, causing such symptoms as palpitations, fatigue, and syncope, which eventually require implantation of a pacemaker device (1) . Elevated resting heart rate, in contrast, is associated with increased cardiovascular mortality and morbidity (2, 3) . Despite the importance of cardiac pacemaking as a physiological process, the complex mechanisms underlying SAN automaticity and heart rate regulation remain incompletely understood. SAN activity is controlled by the autonomic nervous system; cholinergic and ␤-adrenergic stimulation either slows or accelerates spontaneous SAN activity. Several ionic currents contribute to cardiac automaticity (4) (5) (6) . Some of these currents are targets of regulation by the autonomic nervous system, but their physiological importance is a matter of debate (4, 5) . ''Pacemaker'' f-channels mediating the hyperpolarizationactivated nonselective cation current I f , in particular, are directly regulated by cAMP (7) . These channels are homotetrameric or heterotetrameric complexes of hyperpolarization-activated cyclic nucleotide-gated (HCN) subunits (8) . cAMP binds to the cyclic nucleotide-binding domain (CNBD) and elicits a positive shift in the voltage dependence of activation. Accordingly, the activity of f-channels increases when cellular cAMP levels are elevated (e.g., during sympathetic stimulation) and decreases when they are reduced (e.g., during vagal stimulation) (8) . Although these biophysical properties seem to make f-channels ideal molecular targets for heart rate regulation, the contribution of the major I f -mediating cardiac isoforms HCN2 and HCN4 to SAN function remains highly controversial. Although human genetic (9) (10) (11) (12) and pharmacologic (5, 13, 14) studies suggest a significant role for HCN4 subunits in SAN pacemaking in humans and rodents, recent data from transgenic mouse models have challenged this view (15, 16) . Targeted deletion of HCN4 in adult mice was found to cause heart ratedependent sinus pauses but to have no effect on either basal or maximal heart rate or heart rate regulation (16) . Surprisingly similar observations were made in adult heterozygous knock-in mice expressing a cAMP binding-deficient HCN4 subunit (15) . Furthermore, targeted deletion of HCN2 caused sinus dysrhythmia, but did not alter heart rates (17) .
Our study was designed to investigate the role of cAMPdependent modulation of HCN channels in heart rate regulation. Furthermore, we aimed to elucidate the pathophysiologic mechanisms underlying dysfunction or failure of SAN activity associated with a HCN4 mutation (573X) that abolishes cAMP sensitivity of HCN4 channels (12) . Toward this end, we generated transgenic mice with heart-specific and inducible expression of hHCN4-573X and determined the role of cAMP-mediated regulation of HCN channel activity in SAN function.
We analyzed the levels of ␣MHC promoter-driven expression of hHCN4-573X mRNA and protein in the hearts of doubletransgenic mice from 2 independent founder lines (A and F). Animals of both lines expressed detectable levels of transgenespecific mRNA (Fig. 1C) or protein ( Fig. 1D ) in heart tissue, although to different extents. The expression of hHCN4-573X was higher in line F mice than in line A mice. In both founder lines, hHCN4-573X immunoreactivity was high in the atria and almost absent in ventricles (Fig. 1E) . In both lines, the use of the Tet-Off system was functional, as indicated by efficient suppression of transgene expression by the addition of doxycycline (DOX) to the drinking water (Fig. 1F) . After DOX withdrawal, transgene expression was restored after 4 weeks in the line F mice and after 6 weeks in the line A mice. Compared with endogenous mHCN4 protein levels, hHCN4-573X expression was lower in the line A mice and almost identical in the line F mice (Fig. 1F) . Double-transgenic mutants (without DOX treatment) from both founder lines were born at Mendelian ratios and were viable. Echocardiography showed normal ventricular size and function in (G) I f activation curves in control (black squares) and mutant cells (black circles) (26) . If in mutant cells activated at more negative voltages than in control cells. In control cells, application of ISO caused a significant shift in the I f activation curve to more positive voltages (red squares). In contrast, no significant ISO-dependent shift was observed in mutant cells (red circles). (H) Analysis of ␤-adrenergic regulation of ICa,L in control and mutant cells. The bar graph shows current-time integrals of I Ca,L. ICa,L obtained from the same set of experiments shown in (C-F). ICa,L was activated by depolarizing voltage steps from a holding potential of Ϫ60 mV to Ϫ35 mV. At this test voltage, I Ca,L is generated predominantly by Cav1.3 channels (29) . ICa,L was recorded in normal Tyrode's solution (Tyr) at 35°C with and without 100 nM ISO. I Ca,L in control (n ϭ 5; filled bars) and mutant SAN cells (n ϭ 5; open bars) was similarly stimulated by application of ISO. I Ca,L waveform was integrated over a time interval of 60 ms starting from the current onset (30). *P Ͻ .05. Responder Line (20) . (C) Northern blot detection of hHCN4 -573X-specific RNA in total cardiac RNA samples from offspring of 2 independent founder lines (A and F) revealing 2 different expression levels. Total RNA isolated from a wild-type mouse heart was used as a negative control (''Ϫ''). In vitro-synthesized hHCN4 cRNA (100 pg) was added to the control RNA as a positive control (''ϩ''). (D) Western blot detection of transgenic hHCN4 -573X proteins in total heart tissue lysates from double-transgenic (mutant) offspring of both founder lines and from a nontransgenic control mouse (''Ϫ''). Total lysates of human embryonic kidney (HEK-293) cells transiently transfected with hHCN4 -573X were used as a positive control (12) . (E) Region-specific Western blot analysis of proteins isolated from the right atrium (RA), left atrium (LA), right ventricle (RV), and left ventricle (LV). hHCN4 -573X protein was detectable in atrial tissue lysates from both founder lines, whereas ventricular transgene expression was detected only in line F. (F) DOX-dependent regulation of hHCN4 -573X expression and comparison with endogenous mHCN4 protein levels analyzed by Western blot. Total heart lysates were obtained from mutants on DOX (''D'') and from DOX-water (''DW'') animals. Abbreviations: tTA, Tet-Off system transactivator; Tre, tetracycline-responsive element; CT, crista terminalis, SVC, superior vena cava.
the line F mutants [supporting information (SI) Fig. S1 A-E], which had detectable levels of hHCN4-573X in their ventricles (Fig. 1E) . The left ventricular mass to body weight and atrial mass to body weight ratios were normal as well (Fig. S1 F and G) . Fig. 2A and B) . In addition, I f was insensitive to ␤-adrenergic stimulation with isoproterenol (ISO) across the entire voltage range tested ( Fig. 2C-G (Fig. 2H ).
The loss of ISO regulation of I f was associated with profound changes in SAN cell automaticity. All SAN cells from control mice displayed regular and sustained pacemaker activity under basal conditions (no ISO stimulation, n ϭ 15; Fig. 3A and B) and accelerated pacing rates after application of 2 nM and 100 nM ISO (n ϭ 12; Fig. 3A-C) . In contrast, only 2 of 18 mutant SAN cells tested displayed regular pacemaker activity under basal conditions; 11 cells were arrhythmic and alternated between action potentials and subthreshold membrane potential oscillations, and 5 cells were quiescent (Fig. 3A, B, and D) . Application of ISO onto mutant SAN cells (n ϭ 10) induced a dose-dependent acceleration of pacemaking similar to that observed in control cells (Fig. 3C) . ISO application also resulted in restoration of regular pacemaker activity in arrhythmic mutant cells (Fig. 3B ) and resumption of pacemaker activity in 3 of the 5 quiescent cells, thereby reducing the percentage of quiescent cells in the overall cell population (Fig. 3D) . But even at a saturating concentration of ISO, the pacing rate of mutant SAN cells was significantly slower than that of controls ( Fig. 3C ; Table  S1 ). Analysis of action potential properties in mutant SAN cells revealed a compound effect of hHCN-573X expression that included a strong reduction in the slope of diastolic depolarization, a more positive maximum diastolic potential, and prolonged action potential duration ( Table 2 ). Analysis of ISO-induced diastolic currents in SAN cells from control and mutant mice in the presence of the selective I f inhibitor ivabradine (IVA) revealed no significant differences (Fig. S2) ; however, under basal conditions, a small shift in total membrane current in the inward direction during the action potential (membrane potential between 0 and Ϫ20 mV) was seen (Fig. S2) .
Taken together, our data indicate that an hHCN4-573X-linked (Table S1 ). (D) The percentage of quiescent pacemaker cells decreased in a dose-dependent manner on superfusion with 2 nM or 100 nM ISO. ***P Ͻ .001.) Values are given Ϯ SEM. Differences in parameters between groups were tested using an unpaired Student t test. Current density values were measured at a test potential of Ϫ140 mV. Activation time constants were measured at the corresponding I f half-activation voltage (V1/2) in each mouse strain (Ϫ100 in control cells and Ϫ120 mV in mutant cells). Note that ISO (100 nM) did not elicit a positive shift in the V 1/2 or accelerate the If activation kinetics in mutant SAN cells (line A).
loss of cAMP sensitivity of f-channels causes impaired basal cellular automaticity and a reduction in the maximum firing rate of SAN pacemaker cells, but no elimination of ␤-adrenergic regulation of cellular automaticity.
Reduced Basal and Exercise-Induced Heart Rates in hHCN4 -573X-Expressing Mice. To investigate how the cellular changes in isolated SAN pacemaker cells influence the heart rates of intact animals, we used ECG telemetry in conscious mice. First, we tested whether pharmacologic blockade of I f differently affected the heart rate of mutants (line A, no DOX treatment) and controls using IVA (21) . IVA inhibits f-channels by entering the intracellular side of the channel pore in a manner independent of cAMP binding to the CNBD (8) . In the presence of IVA, blocking of I f was comparable in the control and mutant SAN cells (Fig. 4A ). The use of experimental doses of IVA in in vivo pilot experiments showed that IVA-induced heart rate reduction in the control mice was maximal at doses ranging from 3 to 6 mg/kg of body weight (data not shown). Intraperitoneal administration of 3 or 6 mg/kg IVA caused a significant decrease in heart rate in the controls (Fig, 4B) . In striking contrast, IVA had no effect on heart rate in the mutants (Fig.  4C) , demonstrating that the contribution of I f to SAN function was specifically and completely eliminated by the hHCN4-573X transgene.
To avoid possible confounding effects of hHCN4-573X expression during development, additional mice were raised on DOX, implanted with the telemetry device, and then switched to water (DW mutants), to induce transgene expression (Fig. 5A) . The activity-dependent heart rate was identical in the DW mutants and control mice (Fig. 5B) . On DOX withdrawal, DW mutants, unlike controls, exhibited significantly lower heart rates at all activity levels (Fig. 5C) . Surprisingly, the relative activity-induced increase in heart rate (i.e., the difference between maximum and minimum heart rates) was unchanged in these mice ( Fig. 5B-E) . These findings reveal the contribution of effectors of autonomic nervous system modulation of heart rate other than I f , such as I KACh , I Ca,L , I st , and ryanodine receptor-mediated Ca 2ϩ release (5, 6) . In line with this conclusion, the differences between mutants and controls were abolished by the pharmacologic blockade of autonomic nervous system-mediated heart rate regulation using atropine and propranolol (Fig. 5D ). In addition, 24-hour heart rate histograms showed that the relative extent of SAN regulation was comparable in the control mice and DW mutants, although a marked left shift in the SAN frequency range was seen in DW mutants ( Fig. 5F and G). This difference disappeared after the application of atropine and propranolol ( Fig. 5F and G) . No conduction abnormalities or SAN dysrhythmias were observed in the DW mutants on suppression of transgene expression by DOX administration, after DOX withdrawal (Figs. 5H and S3), or during pharmacologic autonomic nervous system-mediated blockade (data not shown). Discussion SAN automaticity is generated through a complex interplay of membrane ion channels, spontaneous intracellular Ca 2ϩ release, and transporters (4, 5) . The relative contribution of these effectors to autonomic nervous system-mediated regulation of heart rate is a matter of debate (4, 5, 22) . In particular, the role of HCN channels as the dominant mechanism in heart rate regulation has repeatedly been called into question (4, 23) . Human genetic studies have suggested that HCN4 channels are important components of the SAN pacemaker machinery (9) (10) (11) (12) . A contribution of I f to heart rate determination is further supported by the observation of a heart rate-lowering effect in both humans and rodents when I f is specifically blocked with IVA (13, 14, 24) . Surprisingly, however, studies of knockout (16, 17) and knock-in (15) mouse models of HCN genes have not demonstrated abnormal heart rates at rest or during ␤-adrenergic stimulation in adult animals.
Our study focused on the functional role of autonomic nervous system-mediated modulation of HCN channel activity via intracellular cAMP levels and its relevance to heart rate regulation. We generated transgenic mice with heart-specific and inducible expression of dominant-negative cAMP binding-deficient HCN4 subunits. In contrast to Harzheim et al. (15) , who generated a similar cAMP-insensitive HCN4 subunit by mutating the cAMP-binding site of the CNBD (R669Q), we introduced a natural HCN4 mutation (573X) that we had identified previously (12) . Among the HCN4 mutations identified to date, this mutation is unique, because the reported clinical symptoms include not only resting This table shows basal cellular pacemaker activity in the absence of ISO stimulation. Thus SAN cell firing rates differ from those shown in Fig. 3C . Cells from mutant animals that were completely quiescent (n ϭ 5) and cells in which the slope of diastolic depolarization was too low to allow accurate measurement (n ϭ 3) were excluded from this analysis. Differences in parameters between groups were tested using an unpaired Student t test. Values are given as mean Ϯ SEM.
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n.s. n.s. Mean heart rate in control mice (B; n ϭ 3) and mutant mice (C; n ϭ 4). Each animal received an i.p. injection of physiological saline (0.9% NaCl), followed by IVA at a dose of 3 mg/kg (3 IVA) or 6 mg/kg (6 IVA) at 72-h intervals, to allow washout of the drug. The heart rate was measured for 3 h before injection of either NaCl or IVA and then for 3 h after injection. Note the reduced basal heart rate in the mutant mice. The aforementioned periods for heart rate averaging were selected because IVA reached its maximum effect 2 h after injection of 3 mg/kg and 1 h after injection of 6 mg/kg (data not shown). Data were compared using ANOVA and the Newman-Keuls posthoc test. *P Ͻ .05.
bradycardia (the key finding in most other patients with HCN4 mutations), but also reduced maximum heart rate during exercise (12) . hHCN4-573X confers cAMP insensitivity to coexpressed wild-type HCN subunits in a dominant-negative manner (12), comparable to the dominant effect of combined deletion of the C-linker (linking transmembrane domain S6 with the CNBD) and the CNBD in HCN2 channels (25) . In contrast, the effect of R669Q in HCN4 (15) likely is comparable to the effect of the corresponding cAMP-binding site mutation R591E in HCN2, which does not completely eliminate the cAMP sensitivity of channels containing wild-type and R591E HCN2 subunits in a 1:1 stoichiometry (25).
Unlike Harzheim et al. (15) , who generated HCN4 R669Q knock-in mice constitutively expressing this cAMP binding-deficient HCN4 subunit throughout prenatal and postnatal life and in all HCN4-expressing tissues, we used the Tet-Off system to induce selective hHCN4-573X transgene expression in the hearts of adult animals. This was particularly important, because the embryonic lethality of homozygous HCN4 R669Q/R669Q mice restricted the in vivo study by Harzheim et al. to heterozygous animals (15) . One advantage of our approach is that transgene expression by DOX withdrawal is not induced before adulthood, preventing possible adaptive changes during development. Another advantage is that each animal may serve as its own control, because it can be recorded both without transgene expression while receiving DOX and with transgene expression after DOX withdrawal.
The presence of the hHCN4-573X transgene in isolated mutant SAN pacemaker cells rendered I f completely insensitive to ␤-adrenergic stimulation, thereby causing a shift in both baseline and ISO-stimulated voltage dependencies by about Ϫ20 mV, resulting in a current activation threshold negative to the maximum diastolic potential. Interestingly, a previous study of cAMP-dependent regulation of native SAN f-channels predicted a Ϫ20-mV shift in the I f activation curve from a switch from a saturating intracellular cAMP concentration to a cAMP-depleted intracellular environment (26) . In line with this assumption, I f in hHCN4-573X-expressing pacemaker cells activated in a negative voltage range, even at maximal ISO-mediated stimulation of the ␤-adrenergic receptor, as if no cAMP was present in the cell. Thus, in mutant cells, I f was ''frozen'' in an activation range negative to that of the diastolic depolarization. Functionally, this negative shift corresponds to an almost complete loss of I f activity at physiological SAN membrane voltages. The absence of a heart rate-lowering effect of IVA in the double-transgenic mutants is consistent with this conclusion. At the cellular level, spontaneous and regular firing of isolated SAN pacemaker cells was impaired. Some cells even failed to generate action potentials, instead exhibiting subthreshold membrane potential oscillations. Although I f amplitudes were not increased by ␤-adrenergic stimulation, ISO application resulted in both a dose-dependent decrease in quiescent cells and a dosedependent increase in spontaneous beating rates (although the 
ECG recordings were obtained from the same animals raised on DOX (B), after withdrawal of DOX (water) (C), and during atropine and propranolol (A/P) administration (D). (B)
Heart rate increased depending on the level of spontaneous home cage activity of control animals (filled bars; n ϭ 4) and mutant animals on DOX (open bars; n ϭ 6). (C) When hHCN4 -573X expression was induced by DOX withdrawal (''on water''), the control mice exhibited the same activity-dependent heart rate as those raised on DOX. The mutant mice on water had a significantly lower heart rate at all activity levels. (D) Heart rates of controls and mutants during autonomic nervous system blockade with A/P. (E) Range of heart rate regulation calculated from the differences between maximum and minimum heart rates in (B-D). (F and G) Histogram of normalized average heart rates recorded during a 24-h period from control (F) and mutant (G; line A) mice on DOX (black), on water (red), and during autonomic nervous system blockade with A/P (blue). (H) Sample ECG raw traces (epochs of 2 s) from control and mutant animals on DOX or water at low and high physical activity levels showing reduced heart rate in mutants, but no signs of SAN dysfunction, conductance abnormalities, or ventricular arrhythmias. For quantification of PQ and QT c interval durations, see latter never reached control levels). The extent of the ISO-induced increase in firing rates observed in spontaneously active SAN cells was comparable in the mutants and controls, however. The marked reduction in spontaneous SAN cell firing rates associated with hHCN4-573X expression was mirrored in the telemetrically measured heart rates of intact conscious mutant mice. These animals had reduced basal heart rates at rest that increased with activity, but not to the levels seen in the same mice during DOX treatment or in control mice. Consistent with the cellular phenotype, the overall range of SAN frequency regulation (i.e., the difference between maximum and resting heart rates) was unchanged.
No SAN dysrhythmia [as present in HCN2 Ϫ/Ϫ mice (17) mice (15)] were observed in hHCN4-573X-expressing DW mutants. A likely explanation for this finding is that even in the absence of ISO, a few SAN cells beat regularly. This small pool of cells might be sufficient to maintain a regular sinus rhythm in the intact organism. Furthermore, in isolated mutant cells, ISO stimulation resulted in elevated spontaneous activity and a reduced number of silent cells. Because the adrenergic drive on SAN cells is significantly higher in an intact organism than in the culture dish, other cAMP-driven signaling pathways may compensate for the absence of I f and thus contribute to the prevention of SAN failure. We found no evidence of any difference in ISO-induced diastolic currents in the presence of IVA between mutants and controls, so the exact mechanisms of this effect remain elusive. Our data provide evidence that I f plays a significant role in setting baseline and maximum SAN firing rates in adult mice by generating a voltage-dependent depolarizing ''offset'' current that is reflected in the slope of diastolic depolarization. These results explain the clinical phenotype of a patient with the same HCN4 mutation that includes resting bradycardia and a reduced heart rate response to exercise ( figure 1 in ref. 12) . They also provide a biological rationale for the clinical efficacy of pharmacologic I f blockade. The preserved relative extent of SAN frequency regulation against the background of ''frozen'' I f activity also unambiguously demonstrates that I f is not a prerequisite for heart rate regulation in adult mice. This finding may have therapeutic relevance, because the range of heart rate regulation in patients treated with IVA for heart rate reduction remains largely unchanged (27) . In addition, our data demonstrate that pacemaker mechanisms other than I f contribute significantly to the positive chronotropic effect of ␤-adrenergic stimulation by targeting effector molecules via protein kinase A or Ca 2ϩ and calmodulin-dependent protein kinase II (CaMKII)-dependent pathways, such as I Ca,L , I st , I NCX , and ryanodine receptor-mediated Ca 2ϩ release (4, 5, 28) .
In summary, our results demonstrate that cAMP-mediated modulation of I f determines basal and maximal heart rates, but not the relative extent of SAN frequency regulation. Furthermore, our study reveals the pathophysiologic mechanism of hHCN4-573X-linked SAN dysfunction, paving the way for the generation of future mouse models for human diseases associated with impaired cardiac automaticity.
Materials and Methods

Generation of Transgenic Mice and Care and Use of Animals. See SI Materials and Methods.
Northern and Western Blot Analyses. RNA or proteins were isolated and analyzed using standard methods, as described in detail in SI Materials and Methods. 
SI Materials and Methods
Generation of Transgenic Mice. The Tet-responsive element (TreTight) of pTRE-Tight (Clontech) was cloned into pWHERE2 v.01 (Invivogen). The complete ORF of hHCN4 (kindly provided by Benjamin Kaupp, Jülich, Germany; GenBank Accession NM005477) was inserted downstream of Tre. A hemagglutinin epitope tag (YPYDVPDYA) was added to the N terminus of hHCN4 by PCR using pcDNA1-hHCN4, as described previously (1) . The single-nucleotide deletion 1631delC was introduced in the HCN4 ORF by site-directed mutagenesis (1), yielding hHCN4-573X. All coding sequences were verified by direct sequencing. Transgenic mice carrying the pWHERETre-hHCN4-573X construct were generated by pronuclear injection using standard techniques. Founder mice and the resulting offspring were genotyped by PCR using ear or tail biopsy specimens. Heart-specific promoter mice [FVB.CgTg(Myh6-tTA)6Smbf/J] (2) were obtained from the Jackson Laboratories and backcrossed to the C57BL/6J strain for more than 4 generations. ''Indicator'' mice expressing GFP and ␤-galactosidase from a bidirectional DOX-sensitive module [Tg(GFPtetO7lacZ)] (3) were used to visualize ␣MHC-driven transgene expression.
Care and Use of Animals. Mixed genotype groups of each gender of no more than 5 animals were housed in standard mouse cages under specific pathogen-free conditions (12:12-h dark-light cycle, constant temperature, constant humidity, and food and water ad libitum). Double-transgenic mice and their tTA transgenic control littermates received either water alone or DOXcontaining drinking water (200 g/mL; Graymor Chemical) when breeding pairs were set up.
The care and use of animals and experimental procedures were in accordance with the German Law for the Protection of Animals and approved by the Ministry of Science and Public Health of the City State of Hamburg, Germany. The study design conforms to the U.S. National Institutes of Health's Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23, revised 1996) and to European directives (86/609/CEE).
RNA Isolation and Northern Blot Analysis.
Mice were deeply anesthetized and killed by cervical dislocation. Hearts were rapidly removed, washed with ice-cold PBS, flash-frozen in liquid nitrogen, and stored at -80°C. Frozen heart tissue was pulverized in liquid nitrogen, homogenized in TRIzol reagent (Invitrogen), and processed according to the manufacturer's protocol. RNA samples (10 g per lane) were separated by electrophoresis on a 1% agarose 0.35% formaldehyde gel and then transferred overnight by capillarity to a Hybond-N membrane (GE Healthcare). The RNAs were fixed on the membrane by baking at 80°C for 1 h. The blot was prehybridized in 6ϫ SSC, 2ϫ Denhardt's solution, and 0.1% SDS for 2 h at 68°C, after which an hHCN4-specific 32 P-labeled probe (25 ng) was added, and the blot was incubated overnight at 68°C. The blot was washed for 20 min in 1ϫ SSC, 0.1% SDS at room temperature and then twice in 0.2ϫ SSC, 0.1% SDS at 68°C. The membrane was exposed to a Kodak Biomax MR film (GE Healthcare) for 3 days at -80°C, then washed and rehybridized with 25 ng of a 32 P-labeled control GAPDH probe (4).
Protein Isolation and Western Blot Analysis. Frozen hearts were pulverized in liquid nitrogen and homogenized in 10% glycerol, 3% SDS, and 62.5 mM Tris (pH 6.8) containing a protease inhibitor mix (Sigma-Aldrich Chemie). Proteins were fractionated on NuPAGE 4%-12% Bis-Tris gels (Invitrogen) in Nu-PAGE Mops SDS running buffer (Invitrogen) and electrophoretically transferred to PROTR AN nitrocellulose membranes (Whatman). Western blot analysis was performed according to standard methods. Antibodies against HCN4 (Alomone Labs; 1:200 dilution) and calsequestrin (Affinity BioReagents; 1:2,500 dilution) were used as primary antibodies.
Isolation of SAN Cells. SAN pacemaker cells were isolated from control and mutant (founder line A) adult mice as described previously (5 The rate of SAN cell pacemaker activity was calculated by counting the number of action potentials in segments of 1-min duration under basal conditions and after application of ISO. The total basal and ISO-induced membrane current was measured by applying a train of digitized action potentials starting from a holding membrane potential of -80 mV (Fig. S2 A) . The train of action potentials was generated by digitizing a representative current clamp recording of a control SAN cell. Membrane series resistance was routinely compensated for electronically up to 90%. The cell membrane capacitance was monitored by applying brief (10 ms) voltage steps of Ϯ 10-mV amplitude from a holding potential of -35 mV. Membrane capacitance was calculated according to
where C m is the membrane capacitance, is the decay time constant of the membrane capacitance transient, and R s ϭ ⌬V/I, where ⌬V is the step amplitude and I is the maximum current level. The value of C m was used to estimate I f current density in each cell. Analysis of I f was performed as described previously (5). Changes in current were thus described according to
where V is the voltage, t is the time, and P is the activation variable. In eq. (2), the activation variable P satisfies the Boltzmann relation
where V 1/2 is the voltage for current half-activation and s is the slope factor. Activation time constants were calculated by fitting singleexponential equations to experimental traces,
where A is a fixed factor, t is time, and t 0 represents the onset of current activation. All fits were performed by numerical iteration using a Levenberg-Marquardt-based numerical algorithm (Origin 7.5 built-in). All results are presented as mean Ϯ SEM.
ECG Analysis. For ECG telemetry, male mice ranging in age from 3 to 4 months were anesthetized with isoflurane and implanted with PhysioTel EA-F20 mouse transmitters (Data Sciences International). Atropine (15 mg/kg body weight/day) and propranolol (5 mg/kg body weight/day) were administered using an osmotic minipump (Alzet; Charles Rivers Laboratories), to avoid handling-induced changes in heart rates. Before undergoing ECG, the mice were allowed to recover for at least 1 week after implantation of the telemetry device and for 2 days after minipump implantation. ECG data were continuously acquired for each animal for at least 72 h using a sampling rate of 1 kHz. Heart rate and cage activity were calculated using 1-minute moving averages from continuous ECG recordings analyzed with Dataquest ART 2.3 (Data Sciences International). Arbitrary activity counts (usually 0-30 aU) were calculated by the recording system (Data Sciences International) as a function of alterations in transmitter signal strength, which changes with locomotor activity, and binned for analysis, with a bin width of 5 counts. The mean heart rate was determined separately for each animal and activity bin, to ensure that each animal had the same weight in the statistical analyses (Fig. 5B-D) .
For the analysis of ECG parameters, 6 ECG epochs of 1 min each per animal and treatment (i.e., DOX, water, and autonomic nervous system blockade) were selected at low activity level (0 aU) and high activity level (Ͼ25 aU). PQ and QT c (7) interval durations were determined using Chart 5 (ADInstruments). Two-way ANOVA and Tukey's honest significant differences (HSD) posthoc test (Statistica; Statsoft) were used for statistical comparison of repetitive measurements in individual mice and subsequent group analysis.
Echocardiography. Two-dimensional echocardiography images were obtained in a modified parasternal long-axis view and a short-axis view at the midpapillary muscle level at a frame rate of 60 Hz (VisualSonics Vevo 660). Mice were kept under light anesthesia (isoflurane 1.8-2.0 vol %) with continuous temperature and ECG monitoring. Echocardiographic studies were performed before and after i.p. injection of the ␤-agonist dobutamine (10 g/g; Carinopharm). Epicardial and endocardial areas of the left ventricular cavity were obtained in a short-axis view during diastole and systole. Area shortening (AS) was calculated by %AS ϭ ͑LV end-diastolic area Ϫ LV end-systolic area͒/ LV end-diastolic area. Left ventricular mass (LVM) was calculated as LVM ϭ ͓1,05 ͑5/6 A1‫͑ء‬L ϩ t͒ Ϫ 5/6 A2‫ء‬L͔͒, [7] where A1 and A2 are the epicardial and endocardial areas, respectively, acquired in a short-axis view, L is the LV diameter (long axis), and t is wall thickness (8) . , LVM-to-body weight ratio (F), or atrial mass-to-body weight ratio (G) were seen between the control (n ϭ 6) and mutant animals (n ϭ 6). Data are given as mean Ϯ SEM and were compared using the Student t test (n.s., not significant). .334
Application of ISO at concentrations of 2 and 100 nM led to a dose-dependent increase in the spontaneous firing rates of control (n ϭ 12) and mutant (n ϭ 10) SAN cells; however, in SAN cells, a saturating dose of ISO (100 nM) had to be added to achieve a pacing rate similar to the basal (unstimulated) rate of control cells. Data are expressed as mean Ϯ SEM and were analyzed by ANOVA and Tukey's HSD post hoc test.
